The studies had similar outcomes: DPP-4 inhibition and sulfonylurea both reduced HbA1c, DPP-4 inhibition had no weight gain, which on the contrary was seen with sulfonylurea, and there was a marked difference in hypoglycemia episodes
Table 1 presents the general characteristics of the participants
The homogenate was filtered through a 100-M cell strainer and centrifuged at 1,000 g for 10 min at 4 C, then the nuclear pellet was washed once in nucleus preparation buffer followed by resuspension in PBS with 1% BSA and 0.2 U l Roche Protector RNase inhibitor
The concern here, of course, is that when patients discontinue these drugs, they regain the weight they lost
+ Hn ch lo ha da
Moving forward, keep a simple dietary log for the first few weeks of tirzepatide therapy to identify which foods feel well-tolerated and which trigger unwanted side effects